Remaining 54 adenocarcinomas, including pancreatic adenocarcinomas (7), liver and bile duct cholangiocarcinomas (11), uterine endometrial carcinomas (7), uterine cervix adenocarcinomas (6), and pulmonary adenocarcinomas including broncho-alveolar type (23), did not show nuclear immunonegativity for AR. This evidence concerns the gene AR and pancreatic adenocarcinoma.